Questionnaire

1. Higher intake of dietary Mg²⁺ has been associated with a reduced risk of all-cause and cancer mortality in a dose-response manner.

2. When evaluating suspected hypomagnesaemia, the preferred test for measuring Mg²⁺ levels is:

3. Hypomagnesaemia is defined as a serum Mg²⁺ level of:

4. Morbidities with which hypomagnesaemia has been associated include:

5. Compared with the general population, the likelihood of hypomagnesaemia in the patient with T2DM is increased:

6. Hypomagnesaemia independently contributes to the development of CVD in T2DM patients.

7. It has been demonstrated that the associations between Mg²⁺ intakes and the risk of gastric cancers are stronger in patients who are:

8. In terms of bone health, Mg²⁺ deficiency affects:

9. Factors that affect intestinal absorption and renal excretion of Mg²⁺ include:

10. Magnesium supplementation in patients with established T2DM seemingly improves biomarkers of:

11. Mg²⁺ supplementation does not lessen hyperglycaemia in T2DM patients with a BMI ≤30kg/m² and diabetes duration of less than 10 years.

12. Systematic review of clinical trial data found that oral Mg²⁺ therapy lowered systolic BP by:

13. A clinical trial of Mg²⁺ supplementation in women being treated for pre-eclampsia found a clinically significant reduced risk for:

14. Regarding the efficacy and safety of different Mg²⁺ salt supplements:

15. Rare adverse effects of prolonged hypermagnesaemia include: